Company Description
XWELL, Inc. provides health and wellness services to travelers in the United States and internationally.
It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler’s spa services, including massage, nail, and skin care services, as well as spa and travel products.
The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC’s bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.
The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services.
The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores, kiosks, and online.
The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022.
XWELL, Inc. is based in New York, New York.
| Country | United States |
| Founded | 2006 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 312 |
| CEO | Ezra Ernst |
Contact Details
Address: 254 West 31st Street, 11th Floor New York, New York 10001 United States | |
| Phone | 212 750 9595 |
| Website | xwell.com |
Stock Details
| Ticker Symbol | XWEL |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001410428 |
| CUSIP Number | 98420U802 |
| ISIN Number | US98420U8027 |
| SIC Code | 7200 |
Key Executives
| Name | Position |
|---|---|
| Ezra T. Ernst | President, Chief Executive Officer and Director |
| Thomas Ian Brown | Chief Financial Officer |
| Cara Soffer | Senior Vice President and General Counsel |
| Mike Heronime | Marketing Director |
| Peter Vermeulen | Head of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 29, 2025 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Apr 28, 2025 | 10-K/A | [Amend] Annual report |
| Apr 21, 2025 | 8-K | Current Report |
| Apr 15, 2025 | 10-K | Annual Report |
| Apr 15, 2025 | 8-K | Current Report |
| Apr 11, 2025 | 8-K | Current Report |
| Mar 31, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 13, 2025 | 8-K | Current Report |
| Mar 5, 2025 | 8-K | Current Report |
| Feb 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |